English | Español
Press release submission | Jun 4, 2021

SQZ Biotechnologies Initial First-In-Human Data Demonstrates Investigational Cell Therapy is Safe and Can Stimulate Immune Responses in Certain Patients with Advanced or Metastatic HPV16+ Tumors
Press release submission | May 25, 2021

More Than 130 Healthcare Groups Express Support for Legislation Expanding Medicare Patients' Access to Pharmacist Services
Press release submission | May 25, 2021

Target RWE COVID-19 Data: Real-World Evidence Analysis Shows 3.6% of COVID-19 Hospitalized Patients Discharged Alive Required Readmission
Press release submission | May 22, 2021

St. Louis Doctor Helps Patients Avoid Unnecessary Diabetic Amputations Using Minimally Invasive Procedure
Press release submission | May 21, 2021

RYBREVANT™ (amivantamab-vmjw) Receives FDA Approval as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Press release submission | May 14, 2021

MEDTRONIC PLC: New Survey Identifies Opportunity to Improve Shared Decision Making Between Cardiologists and Heart Valve Disease Patients

Press release submission | May 13, 2021

AAKP: COVID Pandemic Accelerates International Consortium of Kidney Patients Seeking Care Innovations

Press release submission | May 8, 2021

SAN DIEGO FAMILY CARE: Notifies Patients of Data Security Incident

Trending
+ Pharmaceuticals
Patient Daily | Jun 23, 2025

PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+ Pharmaceuticals
Patient Daily | Jun 19, 2025

Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’
+ Pharmaceuticals
Patient Daily | Jun 19, 2025

FDA loophole lets low-quality drugs from China and India flood U.S. market, while American manufacturers are held to higher standards
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’